Portfolio Category: Current

Glydways

Glydways

Read More
Paragraf

Paragraf

Read More
Phase Four

Phase Four

Read More
Ventyx Biosciences

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Read More
Morrow

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read More
DUST Identity

DUST Identity

Utilizes diamond crystals to enable secure identification of physical objects.

Read More
Isorg

Isorg

Focused on developing an organic photodetector material (OPD) for several commercial applications.

Read More